Guilin Pharmaceutical Co., Ltd. is a subsidiary company of Guilin Pharmaceutical Corp. Ltd.

The main shareholder of Guilin Pharmaceutical Corp. Ltd. is the former Guilin Pharmaceutical Works who carried out the policy and reformed as Guilin pharmaceutical Corp. Ltd. in March 2004, which is formulated by Guilin municipally government to introduce the strategic investors. The other shareholder of Guilin Pharmaceutical Corp. Ltd are Shanghai Fosun High Technology (Group) Co., Ltd. with 20% shares and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. with 40% and natural person with 40% shares who are the employees in the former Guilin Pharmaceutical Works.

The subsidiary companies of Guilin Pharmaceutical Corp. Ltd. are Guilin Pharmaceutical Co., Ltd., Fenghuang Jiangshan Technology Development Company, Chongqing Kangle Pharmaceutical Corp. Ltd. and Guilin Auspicious Pharmaceutical Industrial LTD., which held 94.475%, 95%, 51.57% and 49% shares respectively.

Guilin pharmaceutical Co., Ltd. has a subsidiary company----SGM Company in Australia whose 76.56% shares are held by Guilin Pharma.